Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 This is to inform you that, pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, the Company had published the extract of the Unaudited Financial Results for the quarter ended June 30, 2022 as approved by the Board of Directors in their meeting held on August 10, 2022 in the following newspapers: Free Press Journal (English) dated August 11, 2022 Navshakti (Marathi) dated August 11, 2022
11-08-2022
Bigul

Q1FY23 Quarterly Result Announced for Metropolis Healthcare Ltd.

 Metropolis Healthcare announced Q1FY23 Result : Non-Covid Home Visits revenue increased by 30% YoY Rs. 23 Crs Specialized tests contributed 42% to the Non-Covid revenue EBITDA margin (Before CSR & ESOP) stood at 25.6% Metropolis Healthcare Ltd. records 26% YoY growth in non-covid revenue for Q1FY23 to Rs. 262 Crs Total B2C Revenue grew by 28% YoY in Q1FY23 “I am extremely pleased to share that we have recorded 26% growth on a year-on-year basis for non-covid business inspite of the challenging business environment. Covid and Covid allied revenue witnessed a sharp fall as expected in line with the drop in number of covid cases. Going ahead, we expect the non-covid revenue to revert back to the sustainable growth rates recorded in pre-covid days. We at Metropolis will continue to build our scientific capabilities, expand our network of labs and patient collection centres, build a superior customer experience, and will also focus on wellness and chronic testing segment. We are excited about the differentiation we have been able to create over the years and believe our company has a long runway of growth.” Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd Result PDF
11-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Intimation Of Grant Of Restrictive Stock Units Under The Metropolis Healthcare Limited - Restrictive Stock Unit Plan, 2020

 Pursuant to Regulation 30 of Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'') read with Para B of Part A of Schedule III of Listing Regulations and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 to the extent applicable, we would like to inform you that the Members of Nomination and Remuneration Committee of the Board of Directors of the Company in its Meeting held today i.e. August 10, 2022 have approved grant of 7,000 Restrictive Stock Units under Metropolis Healthcare Limited -Restrictive Stock Unit Plan, 2020 to the eligible employees of the Company
10-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Dear Sir/ Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is the copy of Investor Presentation for the quarter ended June 30, 2022. You are requested to take the above information on record.
10-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Dear Sir/ Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is the Press Release as mentioned below: Metropolis Healthcare Ltd. records 26% YoY growth in non-covid revenue for Q1 FY23 to Rs. 262 Crores. You are requested to take the above information on record.
10-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Results- Unaudited Standalone & Consolidated Financials Results For Quarter Ended June 30,2022

 Dear Sir/ Madam, This is to inform you that the Board of Directors at their Meeting held today i.e. Wednesday, August 10, 2022 have considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022 and took note of the Limited Review Report issued by the Statutory Auditors of the Company thereon. The copy of Unaudited Standalone & Consolidated Financial Results of the Company as approved by the Board of Directors together with the Limited Review Report thereon for the quarter ended June 30, 2022 are enclosed as Annexure - 1. The meeting commenced at 02:00 pm and concluded at 04.25 pm.
10-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30 read with Schedule III to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations') we would like to inform you that the Company will participate in the Q1FY23 Earnings Conference Call (i.e. Post Earnings/Quarterly Call), as organized by Spark Capital on Thursday, August 11,2022 at 9:00 a.m (IST) to discuss the financial results of the Company for the Quarter ended June 30,2022, as per details enclosed herewith.
06-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements pertaining to intimation of Closure of Register of Members and Share Transfer Books published in the following newspapers: 1. Free Press Journal (English Newspaper) 2. NavShakti (Marathi Newspaper) This is for your information and record.
05-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting Scheduled To Be Held On Wednesday, August 10, 2022

 Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 10, 2022, inter alia: To consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2022.
03-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)

 Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SBEI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015, this is to inform you that, Mr. Vijender Singh has tendered his resignation from the position of Chief Executive Officer of Metropolis Healthcare Limited ('Metropolis/ Company') along with any other office or appointments held by him due to personal reasons. Mr. Vijender Singh will continue to be with the Company till the closure of business hours of Wednesday, November 30, 2022. The Management Team and everyone at Metropolis wish the best to Mr. Vijender Singh and are grateful for his contributions in the growth journey of the Company.
29-07-2022
Next Page
Close

Let's Open Free Demat Account